Jan K Horn1. 1. Department of Surgery, University of California and San Francisco General Hospital, San Francisco, California, USA. jhorn@sfghsurg.ucsf.edu
Abstract
BACKGROUND: Bacterial pathogens and their products are potential agents of biological terrorism and biological warfare. These agents can be deployed through simple aerosol delivery systems and thereby cause widespread disease and death. METHODS: This report is a review of bacterial species that have been employed for development of biological terrorism, relying on a system for classification of their threat developed by the Centers for Disease Control. RESULTS: Physicians must understand how to recognize early signs and symptoms caused by bacterial agents. Clinical findings often seen on presentation are emphasized along with a summary of therapeutic approaches. CONCLUSIONS: Initiation of immediate therapy and supportive care provides the best chance for survival from these potentially lethal and devastating infections. A high index of suspicion must be maintained, especially in the setting of a sudden influx of cases with what are often relatively nonspecific symptoms.
BACKGROUND: Bacterial pathogens and their products are potential agents of biological terrorism and biological warfare. These agents can be deployed through simple aerosol delivery systems and thereby cause widespread disease and death. METHODS: This report is a review of bacterial species that have been employed for development of biological terrorism, relying on a system for classification of their threat developed by the Centers for Disease Control. RESULTS: Physicians must understand how to recognize early signs and symptoms caused by bacterial agents. Clinical findings often seen on presentation are emphasized along with a summary of therapeutic approaches. CONCLUSIONS: Initiation of immediate therapy and supportive care provides the best chance for survival from these potentially lethal and devastating infections. A high index of suspicion must be maintained, especially in the setting of a sudden influx of cases with what are often relatively nonspecific symptoms.
Authors: Matthew J Panzner; Arpaporn Deeraksa; Alyssa Smith; Brian D Wright; Khadijah M Hindi; Aysegul Kascatan-Nebioglu; Alfredo G Torres; Barbara M Judy; Christine E Hovis; Julia K Hilliard; Rebekah J Mallett; Emily Cope; D Mark Estes; Carolyn L Cannon; Jeff G Leid; Wiley J Youngs Journal: Eur J Inorg Chem Date: 2009-05-01 Impact factor: 2.524
Authors: Gregory C Whitlock; Arpaporn Deeraksa; Omar Qazi; Barbara M Judy; Katherine Taylor; Katie L Propst; Angie J Duffy; Kate Johnson; G Barrie Kitto; Katherine A Brown; Steven W Dow; Alfredo G Torres; D Mark Estes Journal: Procedia Vaccinol Date: 2010
Authors: Kirill V Korneev; Nikolay P Arbatsky; Antonio Molinaro; Angelo Palmigiano; Rima Z Shaikhutdinova; Mikhail M Shneider; Gerald B Pier; Anna N Kondakova; Ekaterina N Sviriaeva; Luisa Sturiale; Domenico Garozzo; Andrey A Kruglov; Sergei A Nedospasov; Marina S Drutskaya; Yuriy A Knirel; Dmitry V Kuprash Journal: Front Immunol Date: 2015-11-23 Impact factor: 7.561